During the past decade, D & A Research and Genetics conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "D & A Research and Genetics" are "Cardiovascular Disease" (2 trials), "Atherosclerotic Cardiovascular Disease" (1 trials), "Coronary Heart Disease (CHD)" (1 trials), "Heart Failure" (1 trials) and "Hyperlipidemia" (1 trials). Many other conditions were trialed in "D & A Research and Genetics" in a lesser frequency.

Most popular intervention types in "D & A Research and Genetics" are "Drug" (5 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "bococizumab (PF-04950615)" (2 trials), "BMS-986224" (1 trials), "Bococizumab (PF-04950615; RN316)" (1 trials) and "Evolocumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "D & A Research and Genetics" are 6 trials for "All" genders.

Currently, there are NaN active trials in "D & A Research and Genetics". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in D & A Research and Genetics, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in D & A Research and Genetics, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".